Kourie, 2001 - Google Patents

Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity

Kourie, 2001

Document ID
4074154287182365327
Author
Kourie J
Publication year
Publication venue
Chemico-Biological Interactions

External Links

Snippet

Prion-related encephalopathies are associated with the conversion of a normal cellular isoform of prion protein (PrPc) to an abnormal pathologic scrapie isoform (PrPSc). The conversion of this single polypeptide chain involves a reduction in the α-helices and an …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Similar Documents

Publication Publication Date Title
Kourie Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity
Fields et al. Targeting alpha-synuclein as a therapy for Parkinson’s disease
Burré et al. Cell biology and pathophysiology of α-synuclein
Vasili et al. Spreading of α-synuclein and tau: A systematic comparison of the mechanisms involved
Tagliavini et al. Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro
Fan et al. Golgi apparatus and neurodegenerative diseases
Ferreiro et al. The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway
Lee et al. Internalization of mammalian fluorescent cellular prion protein and N‐terminal deletion mutants in living cells
Brown Role of the prion protein in copper turnover in astrocytes
Behensky et al. Afobazole activation of σ-1 receptors modulates neuronal responses to amyloid-β25–35
Haigh et al. Copper binding is the governing determinant of prion protein turnover
Thellung et al. Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106–126
Salmona et al. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity
Aksenov et al. Glutamine synthetase‐induced enhancement of β‐amyloid peptide Aβ (1–40) neurotoxicity accompanied by abrogation of fibril formation and Aβ fragmentation
DeMarco et al. Local environmental effects on the structure of the prion protein
Ricchelli et al. Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann− Sträussler− Scheinker disease peptides in the presence of metal ions
Longhena et al. Targeting of disordered proteins by small molecules in neurodegenerative diseases
Ren et al. Flotillin-1 Mediates PrP C Endocytosis in the Cultured Cells During Cu 2+ Stimulation Through Molecular Interaction
Rana et al. Prion metal interaction: is prion pathogenesis a cause or a consequence of metal imbalance?
Mizuno et al. Involvement of trace elements in the pathogenesis of prion diseases
Pass et al. Prion infection in cells is abolished by a mutated manganese transporter but shows no relation to zinc
Osiecka et al. Prion protein region 23–32 interacts with tubulin and inhibits microtubule assembly
Guo et al. α‐Synuclein decoy peptide protects mice against α‐synuclein‐induced memory loss
Ruttenberg et al. β-Hairpin Alignment Alters Oligomer Formation in Aβ-Derived Peptides
Vieira et al. PrP meets alpha‐synuclein: Molecular mechanisms and implications for disease